Ipsen Completes Acquisition of Clementia Pharmaceuticals
Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult…
Pharmaceuticals, Biotechnology and Life Sciences
Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult…
PANGYO, South Korea & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
IRVINE, Calif.–(BUSINESS WIRE)–The Cystinosis Research Foundation (CRF), the largest provider of grants for cystinosis research in the world, raised a…
Conference Call and Webcast Scheduled for 1:30 p.m. PDT SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its first-quarter 2019 financial results…
– Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc.…
DUBLIN–(BUSINESS WIRE)–The “Protein Expression Market- Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The…
DUBLIN–(BUSINESS WIRE)–The “Global Sciatica Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The analysts have predicted that the…
Earnings call slated for May 17, 6:00 PM IST / 8:30 AM EDT HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE:…